01-3752. Manufacturer of Controlled Substances; Notice of Application  

  • Start Preamble

    Pursuant to section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on August 23, 2000, and December 5, 2000, Cerilliant Corporation, 14050 Summit Drive #121, P.O. Box 201088, Austin, Texas 78708-0189, made application by letter to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below:

    DrugSchedule
    Cathinone (1235)I
    Methcathinone (1237)I
    N-Ethylamphetamine (1475)I
    N,N-Dimethylamphetamine (1480)I
    Aminorex (1585)I
    4-Methylaminorex (cis isomer) (1590)I
    Gamma hydroxybutyric acid (2010)I
    Methaqualone (2565)I
    Alpha-Ethyltryptamine (7249)I
    Lysergic acid diethylamide (7315)I
    Tetrahydrocannabinols (7370)I
    Mescaline (7381)I
    3,4,5-Trimethoxyamphetamine (7390)I
    4-Bromo-2,5-dimethoxyamphetaime (7391)I
    4-Bromo-2,5-dimethoxyphenethylamine (7392)I
    4-Methyl-2,5-dimethoxyamphetamine (7395)I
    2,5-Dimethoxyamphetamine (7396)I
    2,5-Dimethoxy-4-ethylamphetamine (7399)I
    3,4-Methylenedioxyamphetamine (7400)I
    5-Methoxy-3,4-methylenedioxyamphetamine (7401)I
    N-Hydroxy-3,4-methylenedioxyamphetamine (7402)I
    3,4-Methylenedioxy-N-ethylamphetamine (7404)I
    3,4-Methylenedioxymethamphetamine (7405)I
    4-Methoxyamphetamine (7411)I
    Bufotenine (7433)I
    Diethyltryptamine (7434)I
    Dimethyltryptamine (7435)I
    Psilocybin (7437)I
    Psilocyn (7438)I
    Acetyldihydrocodeine (9051)I
    Benzylmorphine (9052)I
    Codeine-N-oxide (9053)I
    Dihydromorphine (9145)I
    Heroin (9200)I
    Morphine-N-oxide (9307)I
    Normorphine (9313)I
    Pholcodine (9314)I
    Acetylmethadol (9601)I
    Allyprodine (9602)I
    Alphacetylmethadol except Levo-Alphacetylmethadol (9603)I
    Alphameprodine (9604)I
    Alphamethadol (9605)I
    Betacetylmethadol (9607)I
    Betameprodine (9608)I
    Betamethadol (9609)I
    Betaprodine (9611)I
    Hydromorphinol (9627)I
    Noracymethadol (9633)I
    Norlevorphanol (9634)I
    Normethadone (9635)I
    Trimeperidine (9646)I
    Para-Fluorofentanyl (9812)I
    3-Methylfentanyl (9813)I
    Alpha-methylfentanyl (9814)I
    Acetyl-alpha-methylfentanyl (9815)I
    Beta-hydroxyfentanyl (9830)I
    Beta-hydroxy-3-methylfentanyl (9831)I
    Start Printed Page 10321
    Alpha-Methylthiofentanyl (9832)I
    3-Methylthiofentanyl (9833)I
    Thiofentanyl (9835)I
    Amphetamine (1100)II
    Methamphetamine (1105)II
    Phenmetrazine (1631)II
    Methylphenidate (1724)II
    Amobarbital (2125)II
    Pentobarbital (2270)II
    Secobarbital (2315)II
    Glutethimide (2550)II
    Nabilone (7379)II
    1-Phenylcyclohexylamine (7460)II
    Phencyclidine (7471)II
    1-Piperidinocyclohexanecarbonitrile (8603)II
    Alphaprodine (9010)II
    Cocaine (9041)II
    Codeine (9050)II
    Dihydrocodeine (9120)II
    Oxycodone (9143)II
    Hydromorphone (9150)II
    Diphenoxylate (9170)II
    Benzoylecgonine (9180)II
    Ethylmorphine (9190)II
    Hydrocodone (9193)II
    Levomethorphan (9210)II
    Levorphanol (9220)II
    Isomethadone (9226)II
    Meperidine (9230)II
    Methadone (9250)II
    Methadone-intermediate (9254)II
    Morphine (9300)II
    Thebaine (9333)II
    Levo-alphacetylmethadol (9648)II
    Oxymorphone (9652)II
    Noroxymorphone (9668)II
    Alfentanil (9737)II
    Sufentanil (9740)II
    Fentanyl (9801)II

    The firm plans to manufacture small quantities of the listed controlled substances to make deuterated and non-deuterated drug reference standards which will be distributed to analytical and forensic laboratories for drug testing programs.

    Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration.

    Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than April 16, 2001.

    Start Signature

    Dated: January 25, 2001.

    Laura M. Nagel,

    Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

    End Signature End Preamble

    [FR Doc. 01-3752 Filed 2-13-01; 8:45 am]

    BILLING CODE 4410-09-M

Document Information

Published:
02/14/2001
Department:
Drug Enforcement Administration
Entry Type:
Notice
Document Number:
01-3752
Pages:
10320-10321 (2 pages)
PDF File:
01-3752.pdf